OLANZAPINE

OLANZAPINE was reported 69867 times

These side effects are most commonly reported by patients taking OLANZAPINE:

# Side effect Count
0 DRUG INEFFECTIVE 7555
1 WEIGHT INCREASED 6911
2 OFF LABEL USE 6127
3 DIABETES MELLITUS 5418
4 TOXICITY TO VARIOUS AGENTS 4386
5 DRUG INTERACTION 4298
6 NAUSEA 4140
7 SOMNOLENCE 4029
8 FATIGUE 3681
9 OVERDOSE 3490
10 ANXIETY 3483
11 VOMITING 3357
12 SUICIDE ATTEMPT 3256
13 CONDITION AGGRAVATED 3029
14 CONFUSIONAL STATE 2933
15 INSOMNIA 2906
16 AGITATION 2806
17 DEATH 2789
18 NEUROLEPTIC MALIGNANT SYNDROME 2756
19 FALL 2747
20 DEPRESSION 2677
21 PSYCHOTIC DISORDER 2660
22 TREMOR 2651
23 DIZZINESS 2635
24 PYREXIA 2607
25 SEDATION 2597
26 DIARRHOEA 2563
27 INTENTIONAL OVERDOSE 2515
28 HYPERTENSION 2511
29 SUICIDAL IDEATION 2504
30 COMPLETED SUICIDE 2480
31 DYSPNOEA 2373
32 PNEUMONIA 2346
33 TACHYCARDIA 2286
34 DRUG ABUSE 2251
35 SCHIZOPHRENIA 2249
36 HYPOTENSION 2216
37 NEUTROPENIA 2194
38 MALAISE 2178
39 ASTHENIA 2163
40 ELECTROCARDIOGRAM QT PROLONGED 2079
41 HEADACHE 2026
42 CONSTIPATION 2014
43 TYPE 2 DIABETES MELLITUS 1950
44 AGGRESSION 1913
45 PANCREATITIS 1911
46 WEIGHT DECREASED 1814
47 EXTRAPYRAMIDAL DISORDER 1786
48 PAIN 1725
49 COMA 1702
50 AKATHISIA 1646
51 PRODUCT USE IN UNAPPROVED INDICATION 1646
52 LOSS OF CONSCIOUSNESS 1597
53 HYPERGLYCAEMIA 1592
54 HALLUCINATION 1554
55 BLOOD GLUCOSE INCREASED 1546
56 GENERAL PHYSICAL HEALTH DETERIORATION 1545
57 DYSKINESIA 1544
58 FEBRILE NEUTROPENIA 1536
59 DECREASED APPETITE 1516
60 TREATMENT NONCOMPLIANCE 1499
61 HALLUCINATION, AUDITORY 1496
62 DEPRESSED LEVEL OF CONSCIOUSNESS 1482
63 FEELING ABNORMAL 1468
64 PULMONARY EMBOLISM 1451
65 WHITE BLOOD CELL COUNT DECREASED 1440
66 OBESITY 1417
67 CHEST PAIN 1411
68 DELIRIUM 1410
69 GAIT DISTURBANCE 1406
70 HYPONATRAEMIA 1390
71 SEIZURE 1369
72 DYSTONIA 1329
73 BLOOD CHOLESTEROL INCREASED 1315
74 ACUTE KIDNEY INJURY 1298
75 RASH 1297
76 RESTLESSNESS 1295
77 ANAEMIA 1264
78 DELUSION 1262
79 RHABDOMYOLYSIS 1259
80 ABDOMINAL PAIN 1253
81 INTENTIONAL SELF-INJURY 1253
82 HYPERHIDROSIS 1249
83 METABOLIC DISORDER 1237
84 LEUKOPENIA 1233
85 PRESCRIBED OVERDOSE 1224
86 PARKINSONISM 1218
87 DIABETIC KETOACIDOSIS 1215
88 DEHYDRATION 1205
89 BLOOD TRIGLYCERIDES INCREASED 1187
90 MANIA 1170
91 VISION BLURRED 1148
92 ABNORMAL BEHAVIOUR 1144
93 TARDIVE DYSKINESIA 1143
94 BLOOD CREATINE PHOSPHOKINASE INCREASED 1139
95 THROMBOCYTOPENIA 1132
96 MEMORY IMPAIRMENT 1128
97 SOPOR 1119
98 CARDIAC ARREST 1112
99 DYSARTHRIA 1076
100 OEDEMA PERIPHERAL 1066
101 DYSPHAGIA 1065
102 HOSPITALISATION 1047
103 INJURY 990
104 PLATELET COUNT DECREASED 990
105 ALANINE AMINOTRANSFERASE INCREASED 977
106 MENTAL DISORDER 967
107 URINARY TRACT INFECTION 954
108 DISTURBANCE IN ATTENTION 943
109 SPEECH DISORDER 935
110 PNEUMONIA ASPIRATION 931
111 RENAL FAILURE 928
112 SYNCOPE 926
113 PAIN IN EXTREMITY 924
114 IRRITABILITY 912
115 COGNITIVE DISORDER 898
116 CATATONIA 897
117 FOETAL EXPOSURE DURING PREGNANCY 893
118 ARTHRALGIA 880
119 MENTAL IMPAIRMENT 878
120 HAEMOGLOBIN DECREASED 876
121 MYOCARDIAL INFARCTION 869
122 MYOCARDITIS 866
123 SEROTONIN SYNDROME 865
124 HYPOGLYCAEMIA 864
125 SEPSIS 862
126 BACK PAIN 861
127 NEUTROPHIL COUNT DECREASED 846
128 DISORIENTATION 840
129 CARDIO-RESPIRATORY ARREST 832
130 MUSCLE RIGIDITY 832
131 ASPARTATE AMINOTRANSFERASE INCREASED 827
132 INCREASED APPETITE 823
133 SEXUAL DYSFUNCTION 811
134 PARANOIA 797
135 CONVULSION 786
136 SALIVARY HYPERSECRETION 774
137 COUGH 768
138 CEREBROVASCULAR ACCIDENT 755
139 ABDOMINAL PAIN UPPER 751
140 AMNESIA 748
141 MUSCLE SPASMS 744
142 HEART RATE INCREASED 734
143 LETHARGY 730
144 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 727
145 INTENTIONAL PRODUCT MISUSE 718
146 BALANCE DISORDER 706
147 PRURITUS 703
148 MUSCULOSKELETAL STIFFNESS 702
149 URINARY RETENTION 696
150 RESPIRATORY FAILURE 695
151 WHITE BLOOD CELL COUNT INCREASED 683
152 PRODUCT USE ISSUE 682
153 BLOOD PRESSURE INCREASED 680
154 SLEEP DISORDER 673
155 DEEP VEIN THROMBOSIS 669
156 DRY MOUTH 665
157 HYPERPROLACTINAEMIA 664
158 C-REACTIVE PROTEIN INCREASED 658
159 PALPITATIONS 658
160 BRADYCARDIA 653
161 DEPRESSED MOOD 653
162 NEUROPATHY PERIPHERAL 646
163 HEPATIC ENZYME INCREASED 639
164 DRUG LEVEL INCREASED 633
165 ALTERED STATE OF CONSCIOUSNESS 631
166 DRUG WITHDRAWAL SYNDROME 630
167 HYPOAESTHESIA 629
168 PANCYTOPENIA 626
169 HYPOKALAEMIA 625
170 DIABETIC COMA 616
171 WITHDRAWAL SYNDROME 615
172 HALLUCINATION, VISUAL 614
173 MYALGIA 614
174 MEDICATION ERROR 610
175 MENTAL STATUS CHANGES 610
176 ALOPECIA 603
177 ADVERSE DRUG REACTION 601
178 UNRESPONSIVE TO STIMULI 598
179 DIABETES MELLITUS NON-INSULIN-DEPENDENT 594
180 BLOOD CREATININE INCREASED 593
181 VISUAL IMPAIRMENT 587
182 BIPOLAR DISORDER 583
183 ARRHYTHMIA 582
184 TREATMENT FAILURE 578
185 EMOTIONAL DISTRESS 573
186 PERSONALITY CHANGE 573
187 EXPOSURE DURING PREGNANCY 571
188 SINUS TACHYCARDIA 570
189 HYPOTHERMIA 562
190 GASTROOESOPHAGEAL REFLUX DISEASE 555
191 CARDIAC DISORDER 554
192 INFECTION 554
193 BLOOD PROLACTIN ABNORMAL 551
194 DRUG INTOLERANCE 549
195 PARAESTHESIA 548
196 DRUG EXPOSURE DURING PREGNANCY 543
197 PERIPHERAL SWELLING 543
198 PSYCHOMOTOR HYPERACTIVITY 542
199 SCHIZOAFFECTIVE DISORDER 536
200 HYPERLIPIDAEMIA 533
201 HYPERSOMNIA 533
202 MUSCULAR WEAKNESS 533
203 THERAPY NON-RESPONDER 533
204 CHOLELITHIASIS 532
205 PRODUCT DOSE OMISSION ISSUE 530
206 THINKING ABNORMAL 529
207 MIOSIS 517
208 OBSESSIVE-COMPULSIVE DISORDER 508
209 URINARY INCONTINENCE 508
210 RESPIRATORY ARREST 505
211 AGRANULOCYTOSIS 501
212 ABDOMINAL DISTENSION 497
213 RENAL IMPAIRMENT 497
214 ABDOMINAL DISCOMFORT 487
215 APATHY 483
216 GYNAECOMASTIA 482
217 MATERNAL EXPOSURE DURING PREGNANCY 481
218 CARDIAC FAILURE 478
219 ANOSOGNOSIA 477
220 DISTURBANCE IN SOCIAL BEHAVIOUR 476
221 COVID-19 474
222 PANIC ATTACK 470
223 BLOOD PROLACTIN INCREASED 468
224 DRUG DEPENDENCE 460
225 RESPIRATORY DEPRESSION 457
226 ANGER 455
227 CHILLS 453
228 EPILEPSY 450
229 DISEASE PROGRESSION 446
230 HYPOXIA 446
231 INCORRECT DOSE ADMINISTERED 445
232 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 440
233 DRUG HYPERSENSITIVITY 439
234 LEUKOCYTOSIS 438
235 DIABETES MELLITUS INADEQUATE CONTROL 435
236 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 434
237 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 432
238 HYPERSENSITIVITY 431
239 OXYGEN SATURATION DECREASED 428
240 PANCREATITIS ACUTE 424
241 HEPATIC STEATOSIS 422
242 ERECTILE DYSFUNCTION 421
243 TYPE 1 DIABETES MELLITUS 420
244 ERYTHEMA 419
245 GAMMA-GLUTAMYLTRANSFERASE INCREASED 418
246 RENAL FAILURE ACUTE 418
247 ATRIAL FIBRILLATION 417
248 METABOLIC SYNDROME 414
249 NEUTROPHIL COUNT INCREASED 410
250 HYPOMANIA 408
251 ORTHOSTATIC HYPOTENSION 406
252 MUSCLE TWITCHING 403
253 PULMONARY OEDEMA 403
254 METABOLIC ACIDOSIS 398
255 MOVEMENT DISORDER 397
256 BLOOD CHOLESTEROL ABNORMAL 396
257 GENERALISED TONIC-CLONIC SEIZURE 396
258 OEDEMA 394
259 DRUG RESISTANCE 390
260 ACCIDENTAL OVERDOSE 388
261 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 386
262 DYSLIPIDAEMIA 385
263 CONTUSION 384
264 CELLULITIS 383
265 PSYCHOTIC SYMPTOM 382
266 DIABETIC NEUROPATHY 380
267 BLOOD PRESSURE DECREASED 379
268 HAEMATOCRIT DECREASED 379
269 POLYDIPSIA 378
270 BLOOD ALKALINE PHOSPHATASE INCREASED 377
271 DYSPEPSIA 377
272 POISONING 376
273 PLEURAL EFFUSION 375
274 HEPATIC FUNCTION ABNORMAL 374
275 LIVER FUNCTION TEST ABNORMAL 369
276 EPISTAXIS 368
277 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 367
278 POISONING DELIBERATE 367
279 BLOOD BILIRUBIN INCREASED 365
280 NASOPHARYNGITIS 364
281 SEPTIC SHOCK 363
282 OCULOGYRIC CRISIS 357
283 DRUG TOXICITY 356
284 GASTROINTESTINAL DISORDER 353
285 CARDIAC FAILURE CONGESTIVE 351
286 DRUG-INDUCED LIVER INJURY 351
287 ENCEPHALOPATHY 351
288 EUPHORIC MOOD 351
289 EATING DISORDER 350
290 MIGRAINE 342
291 DYSURIA 341
292 SOCIAL AVOIDANT BEHAVIOUR 341
293 EOSINOPHILIA 340
294 NERVOUSNESS 340
295 OROPHARYNGEAL PAIN 339
296 THERAPEUTIC RESPONSE DECREASED 339
297 HYPERTHERMIA 335
298 POLLAKIURIA 335
299 APHASIA 334
300 DISEASE RECURRENCE 330
301 CHEST DISCOMFORT 329
302 HYPOPHAGIA 329
303 BRONCHITIS 327
304 GASTROINTESTINAL HAEMORRHAGE 326
305 POST-INJECTION DELIRIUM SEDATION SYNDROME 326
306 LIVER DISORDER 324
307 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 323
308 RESPIRATORY DISTRESS 321
309 FEAR 318
310 INTESTINAL OBSTRUCTION 316
311 SUDDEN DEATH 313
312 DEMENTIA 312
313 JOINT SWELLING 311
314 STRESS 310
315 DRUG DOSE OMISSION 309
316 HEAD INJURY 306
317 HEPATOTOXICITY 305
318 ADVERSE EVENT 303
319 EMOTIONAL DISORDER 302
320 MALIGNANT NEOPLASM PROGRESSION 301
321 LYMPHOCYTE COUNT DECREASED 300
322 NIGHTMARE 300
323 VERTIGO 300
324 ANTIPSYCHOTIC DRUG LEVEL INCREASED 299
325 HYPOTHYROIDISM 299
326 MAJOR DEPRESSION 299
327 CHRONIC KIDNEY DISEASE 298
328 POLYURIA 298
329 RED BLOOD CELL COUNT DECREASED 298
330 MYOCLONUS 297
331 TINNITUS 296
332 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 292
333 MUCOSAL INFLAMMATION 291
334 CARDIOMYOPATHY 290
335 BRADYPHRENIA 289
336 INFLUENZA 288
337 AFFECTIVE DISORDER 287
338 DROOLING 286
339 INTENTIONAL PRODUCT USE ISSUE 286
340 THROMBOSIS 285
341 ASPIRATION 284
342 ASTHMA 282
343 SWELLING 281
344 BRAIN INJURY 280
345 MOOD SWINGS 279
346 PERSECUTORY DELUSION 279
347 PSYCHIATRIC SYMPTOM 279
348 MOBILITY DECREASED 278
349 RENAL DISORDER 277
350 MYDRIASIS 274
351 RESTLESS LEGS SYNDROME 273
352 SLEEP APNOEA SYNDROME 272
353 TRANSAMINASES INCREASED 272
354 TROPONIN INCREASED 272
355 DISINHIBITION 271
356 DRY SKIN 269
357 HEPATOCELLULAR INJURY 267
358 AMENORRHOEA 266
359 HYPERCHOLESTEROLAEMIA 264
360 INFLUENZA LIKE ILLNESS 264
361 MOOD ALTERED 263
362 BLOOD SODIUM DECREASED 262
363 PSYCHIATRIC DECOMPENSATION 262
364 TACHYPNOEA 260
365 SWELLING FACE 259
366 UNDERDOSE 259
367 THIRST 256
368 URTICARIA 255
369 HAEMORRHAGE 253
370 BODY TEMPERATURE INCREASED 252
371 WHEEZING 252
372 GRANULOCYTOPENIA 251
373 HYPERTRIGLYCERIDAEMIA 251
374 LOWER RESPIRATORY TRACT INFECTION 251
375 PRODUCT SUBSTITUTION ISSUE 251
376 CRYING 250
377 SEDATION COMPLICATION 250
378 VENTRICULAR TACHYCARDIA 248
379 GALACTORRHOEA 247
380 ROAD TRAFFIC ACCIDENT 247
381 GESTATIONAL DIABETES 245
382 SUBSTANCE ABUSE 244
383 DISCOMFORT 243
384 TRANSIENT ISCHAEMIC ATTACK 243
385 GLUCOSE TOLERANCE IMPAIRED 242
386 NERVOUS SYSTEM DISORDER 241
387 THERAPY CESSATION 241
388 HYPERKALAEMIA 240
389 BRADYKINESIA 239
390 RECTAL HAEMORRHAGE 238
391 ANHEDONIA 237
392 ANTICHOLINERGIC SYNDROME 236
393 HALLUCINATIONS, MIXED 234
394 ABNORMAL WEIGHT GAIN 233
395 ACUTE RESPIRATORY FAILURE 232
396 ATAXIA 231
397 PRIAPISM 231
398 UPPER RESPIRATORY TRACT INFECTION 231
399 BLINDNESS 230
400 HEPATIC FAILURE 230
401 CIRCULATORY COLLAPSE 229
402 PSYCHOMOTOR RETARDATION 226
403 FLUID RETENTION 225
404 BLOOD GLUCOSE ABNORMAL 223
405 TORSADE DE POINTES 223
406 POOR QUALITY SLEEP 222
407 THERAPY PARTIAL RESPONDER 221
408 HEPATITIS 220
409 ILL-DEFINED DISORDER 220
410 PERICARDIAL EFFUSION 220
411 SINUSITIS 220
412 CYTOKINE RELEASE SYNDROME 219
413 NECK PAIN 218
414 GLYCOSYLATED HAEMOGLOBIN INCREASED 216
415 LUNG NEOPLASM MALIGNANT 215
416 SHOCK 215
417 HYPERPHAGIA 214
418 DIPLOPIA 213
419 HUNGER 213
420 HYPOKINESIA 212
421 PLASMA CELL MYELOMA 212
422 MULTIPLE ORGAN DYSFUNCTION SYNDROME 211
423 PREMATURE BABY 211
424 BLOOD LACTATE DEHYDROGENASE INCREASED 210
425 ILLNESS 210
426 KETOACIDOSIS 210
427 SINUS BRADYCARDIA 210
428 APLASTIC ANAEMIA 209
429 HYPOCALCAEMIA 209
430 LACTIC ACIDOSIS 209
431 UNEVALUABLE EVENT 209
432 STOMATITIS 208
433 HYPOTONIA 207
434 JAUNDICE CHOLESTATIC 207
435 BRAIN OEDEMA 206
436 EOSINOPHIL COUNT INCREASED 206
437 PALLOR 205
438 DRUG USE DISORDER 203
439 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 202
440 INTENTIONAL DRUG MISUSE 202
441 REFUSAL OF TREATMENT BY PATIENT 202
442 GRAND MAL CONVULSION 201
443 RHINORRHOEA 201
444 COLITIS 200
445 ELECTROCARDIOGRAM ABNORMAL 200
446 HAEMATEMESIS 199
447 ACUTE RESPIRATORY DISTRESS SYNDROME 198
448 INCONTINENCE 198
449 PLEUROTHOTONUS 198
450 BLOOD POTASSIUM DECREASED 196
451 BURNING SENSATION 196
452 GASTRITIS 195
453 FAECALOMA 194
454 DYSGEUSIA 193
455 STAPHYLOCOCCAL INFECTION 193
456 COORDINATION ABNORMAL 192
457 SOMNAMBULISM 191
458 EMOTIONAL POVERTY 190
459 HEPATIC CYTOLYSIS 190
460 ACUTE MYOCARDIAL INFARCTION 188
461 CORONARY ARTERY DISEASE 188
462 PERICARDITIS 188
463 AFFECT LABILITY 187
464 ANGIOEDEMA 187
465 CARDIAC MURMUR 187
466 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 187
467 CYANOSIS 186
468 ELECTROLYTE IMBALANCE 186
469 HYPERAMMONAEMIA 186
470 MYOCARDIAL ISCHAEMIA 186
471 POSTURE ABNORMAL 186
472 CHOLESTASIS 185
473 COLITIS ISCHAEMIC 185
474 DYSPHONIA 184
475 FLUSHING 184
476 HYPERNATRAEMIA 184
477 CEREBRAL INFARCTION 183
478 LYMPHADENOPATHY 183
479 OVERWEIGHT 183
480 WOUND 182
481 HEART RATE DECREASED 181
482 LUNG DISORDER 181
483 HAEMATOCHEZIA 180
484 INJECTION SITE PAIN 180
485 PULMONARY CONGESTION 180
486 THERAPY INTERRUPTED 180
487 EOSINOPHIL COUNT DECREASED 179
488 LIVER INJURY 179
489 STEVENS-JOHNSON SYNDROME 179
490 VISUAL ACUITY REDUCED 179
491 BEHAVIOUR DISORDER 178
492 NASAL CONGESTION 178
493 PARKINSON^S DISEASE 178
494 PRODUCT PRESCRIBING ERROR 178
495 FLATULENCE 177
496 HYPERTONIA 177
497 NEUROTOXICITY 177
498 PRODUCTIVE COUGH 175
499 RASH MACULO-PAPULAR 175
500 DYSSTASIA 173
501 ILEUS 173
502 VENTRICULAR FIBRILLATION 173
503 JAUNDICE 172
504 ACUTE PSYCHOSIS 171
505 SWOLLEN TONGUE 169
506 CHOKING 168
507 HAEMATURIA 168
508 CATARACT 167
509 VASCULITIS 167
510 CARDIOMEGALY 166
511 MULTIPLE DRUG OVERDOSE 166
512 ILEUS PARALYTIC 165
513 MALNUTRITION 165
514 TENSION 165
515 ASCITES 164
516 FOOD CRAVING 164
517 SYSTEMIC LUPUS ERYTHEMATOSUS 164
518 DRUG EFFECT DECREASED 163
519 FEELING COLD 163
520 MOTOR DYSFUNCTION 163
521 ASPHYXIA 162
522 EYE PAIN 162
523 RESPIRATORY DISORDER 161
524 EJECTION FRACTION DECREASED 160
525 OSTEOPOROSIS 160
526 DIABETES MELLITUS INSULIN-DEPENDENT 159
527 STUPOR 159
528 LIBIDO DECREASED 158
529 ABNORMAL DREAMS 157
530 CEREBRAL HAEMORRHAGE 157
531 CONTRAINDICATED PRODUCT ADMINISTERED 157
532 ARTHRITIS 156
533 BIPOLAR I DISORDER 156
534 COGWHEEL RIGIDITY 156
535 FEELING HOT 156
536 SELF-INJURIOUS IDEATION 156
537 AUTONOMIC NERVOUS SYSTEM IMBALANCE 155
538 BLOOD UREA INCREASED 155
539 IMPULSIVE BEHAVIOUR 154
540 PNEUMONITIS 154
541 CARDIOGENIC SHOCK 153
542 THERAPEUTIC PRODUCT EFFECT VARIABLE 153
543 ACUTE HEPATIC FAILURE 152
544 DEPRESSIVE SYMPTOM 152
545 EYE MOVEMENT DISORDER 151
546 INTERSTITIAL LUNG DISEASE 151
547 ANGINA PECTORIS 149
548 GENERALISED OEDEMA 149
549 GLYCOSURIA 149
550 INFLAMMATION 149
551 PLATELET COUNT INCREASED 149
552 MUSCULOSKELETAL PAIN 148
553 LOGORRHOEA 147
554 DRY EYE 146
555 HYPOACUSIS 146
556 PSORIASIS 146
557 RHINITIS ALLERGIC 146
558 BLOOD GLUCOSE DECREASED 145
559 BLOOD URINE PRESENT 145
560 HEPATITIS C 145
561 PRESYNCOPE 145
562 DISABILITY 144
563 LIVER FUNCTION TEST INCREASED 144
564 INTERNATIONAL NORMALISED RATIO INCREASED 143
565 BUNDLE BRANCH BLOCK RIGHT 141
566 HOT FLUSH 141
567 OSTEOARTHRITIS 141
568 PRODUCT ADMINISTRATION ERROR 141
569 PRODUCT QUALITY ISSUE 141
570 SLUGGISHNESS 141
571 SUDDEN CARDIAC DEATH 141
572 COMA SCALE ABNORMAL 140
573 TOXIC ENCEPHALOPATHY 140
574 FLANK PAIN 139
575 CONGENITAL ANOMALY 138
576 NEPHROPATHY 138
577 RASH PRURITIC 138
578 STATUS EPILEPTICUS 138
579 ACTIVITIES OF DAILY LIVING IMPAIRED 137
580 HIP FRACTURE 137
581 FACE OEDEMA 136
582 RASH ERYTHEMATOUS 136
583 DRUG WITHDRAWAL SYNDROME NEONATAL 135
584 HYPERREFLEXIA 135
585 MITRAL VALVE INCOMPETENCE 135
586 NO ADVERSE EVENT 135
587 RIB FRACTURE 135
588 SCREAMING 135
589 BLISTER 134
590 BLOOD PRESSURE FLUCTUATION 134
591 IMPAIRED WORK ABILITY 134
592 INSURANCE ISSUE 134
593 ACCIDENTAL DEATH 133
594 COMMUNICATION DISORDER 133
595 ENDOCRINE DISORDER 133
596 SELF INJURIOUS BEHAVIOUR 133
597 ABORTION SPONTANEOUS 132
598 DISSOCIATION 132
599 EYE DISORDER 132
600 GAIT INABILITY 132
601 HAEMATOMA 132
602 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 131
603 HOMICIDAL IDEATION 131
604 MUTISM 131
605 POST-TRAUMATIC STRESS DISORDER 131
606 HYPERVENTILATION 130
607 LEFT VENTRICULAR DYSFUNCTION 130
608 PARADOXICAL DRUG REACTION 130
609 DRUG ERUPTION 129
610 THERAPEUTIC AGENT TOXICITY 129
611 DIABETIC COMPLICATION 128
612 HAEMOPTYSIS 128
613 MOUTH ULCERATION 128
614 NEPHROLITHIASIS 128
615 PERSONALITY DISORDER 128
616 THERAPEUTIC RESPONSE UNEXPECTED 128
617 LIP SWELLING 127
618 RED BLOOD CELL SEDIMENTATION RATE INCREASED 127
619 SKIN DISCOLOURATION 127
620 APNOEA 124
621 BLEPHAROSPASM 124
622 BRONCHIECTASIS 124
623 DELUSION OF GRANDEUR 124
624 DRUG LEVEL ABOVE THERAPEUTIC 124
625 NIGHT SWEATS 124
626 BONE PAIN 123
627 HEART RATE IRREGULAR 123
628 ACNE 122
629 ECZEMA 122
630 FLAT AFFECT 122
631 INCOHERENT 122
632 MUSCLE TIGHTNESS 122
633 RESPIRATORY TRACT INFECTION 122
634 TORTICOLLIS 122
635 CEREBRAL ATROPHY 121
636 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 121
637 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 121
638 RENAL INJURY 121
639 SARCOIDOSIS 121
640 SUICIDAL BEHAVIOUR 121
641 HEPATIC CIRRHOSIS 120
642 IMPAIRED GASTRIC EMPTYING 120
643 PANCREATITIS NECROTISING 120
644 ACIDOSIS 119
645 BLOOD PRESSURE SYSTOLIC INCREASED 119
646 DRUG LEVEL DECREASED 119
647 ISCHAEMIC STROKE 119
648 OBSESSIVE THOUGHTS 119
649 VIRAL INFECTION 119
650 ENURESIS 118
651 MULTIPLE DRUG OVERDOSE INTENTIONAL 118
652 PERITONITIS 118
653 ELECTROENCEPHALOGRAM ABNORMAL 117
654 LEUKAEMIA 117
655 LYMPHOPENIA 117
656 MENSTRUATION IRREGULAR 117
657 NEOPLASM MALIGNANT 117
658 CLOSTRIDIUM DIFFICILE INFECTION 116
659 REBOUND EFFECT 116
660 RETCHING 116
661 TIC 116
662 FEELING JITTERY 115
663 GASTROENTERITIS 115
664 HEPATOMEGALY 115
665 LABORATORY TEST ABNORMAL 115
666 LOW DENSITY LIPOPROTEIN INCREASED 115
667 VENTRICULAR ARRHYTHMIA 115
668 HYPERAMMONAEMIC ENCEPHALOPATHY 114
669 SKIN EXFOLIATION 114
670 STARING 114
671 BREAST CANCER 113
672 CAESAREAN SECTION 113
673 HIGH DENSITY LIPOPROTEIN DECREASED 113
674 ORTHOSTATIC HYPERTENSION 113
675 TASTE DISORDER 113
676 VENTRICULAR EXTRASYSTOLES 113
677 DRUG SCREEN POSITIVE 112
678 ECONOMIC PROBLEM 112
679 SUBSTANCE USE DISORDER 112
680 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 112
681 THERAPEUTIC PRODUCT EFFECT DECREASED 112
682 WRONG PATIENT RECEIVED PRODUCT 112
683 ABASIA 111
684 BLOOD POTASSIUM INCREASED 111
685 DRUG EFFECT INCOMPLETE 111
686 HEAD DISCOMFORT 110
687 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 109
688 ANAPHYLACTIC REACTION 109
689 CARDIOVASCULAR DISORDER 109
690 DECUBITUS ULCER 109
691 HYPOALBUMINAEMIA 109
692 SKIN LESION 109
693 BLOOD ALBUMIN DECREASED 108
694 BRAIN FOG 108
695 HAEMODYNAMIC INSTABILITY 108
696 MEGACOLON 108
697 ALCOHOL ABUSE 107
698 CYSTITIS 107
699 FEEDING DISORDER 107
700 INFUSION RELATED REACTION 107
701 SUSPECTED SUICIDE 107
702 CONJUNCTIVITIS 106
703 FULL BLOOD COUNT ABNORMAL 106
704 HYPERCALCAEMIA 106
705 NASAL POLYPS 106
706 PETIT MAL EPILEPSY 106
707 PULMONARY HYPERTENSION 106
708 THERMAL BURN 106
709 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 105
710 IRRITABLE BOWEL SYNDROME 105
711 PRODUCT PRESCRIBING ISSUE 105
712 TOTAL LUNG CAPACITY INCREASED 105
713 TOXIC EPIDERMAL NECROLYSIS 105
714 ARTERIOSCLEROSIS CORONARY ARTERY 104
715 ATRIOVENTRICULAR BLOCK FIRST DEGREE 104
716 COLD SWEAT 104
717 IMPAIRED HEALING 104
718 INSULIN RESISTANCE 104
719 DYSPHORIA 103
720 OCULAR HYPERAEMIA 103
721 PHOTOPHOBIA 103
722 SURGERY 103
723 DEREALISATION 102
724 EYE SWELLING 102
725 INSPIRATORY CAPACITY DECREASED 102
726 IRON DEFICIENCY ANAEMIA 102
727 PSYCHOMOTOR SKILLS IMPAIRED 102
728 ATRIAL SEPTAL DEFECT 101
729 BREAST ENLARGEMENT 101
730 COAGULOPATHY 101
731 DELUSIONAL DISORDER, PERSECUTORY TYPE 101
732 JOINT STIFFNESS 101
733 MULTI-ORGAN FAILURE 101
734 WRONG TECHNIQUE IN DRUG USAGE PROCESS 101
735 ACUTE PULMONARY OEDEMA 100
736 DECREASED ACTIVITY 100
737 GASTRIC ULCER 100
738 RESPIRATORY RATE INCREASED 100
739 ANOREXIA 99
740 BRUXISM 99
741 DYSPNOEA EXERTIONAL 99
742 HERPES ZOSTER 99
743 HYPERTRANSAMINASAEMIA 99
744 HYPOTONIA NEONATAL 99
745 PARALYSIS 99
746 PHOTOSENSITIVITY REACTION 99
747 DRUG LEVEL BELOW THERAPEUTIC 98
748 HICCUPS 98
749 ILLUSION 98
750 IMPAIRED QUALITY OF LIFE 98
751 IMPULSE-CONTROL DISORDER 98
752 PANCREATITIS CHRONIC 98
753 SKIN DISORDER 98
754 TRISMUS 98
755 HAEMORRHOIDS 97
756 HOSTILITY 97
757 NEGATIVISM 97
758 NEURALGIA 97
759 SUPRAVENTRICULAR TACHYCARDIA 97
760 VAGINAL HAEMORRHAGE 97
761 ATELECTASIS 96
762 GLAUCOMA 96
763 QUALITY OF LIFE DECREASED 96
764 SUBARACHNOID HAEMORRHAGE 96
765 TRICUSPID VALVE INCOMPETENCE 96
766 LIMB DISCOMFORT 95
767 PROTEIN URINE PRESENT 95
768 COVID-19 PNEUMONIA 94
769 DIABETIC RETINOPATHY 94
770 HYPOVOLAEMIA 94
771 LIPASE INCREASED 94
772 PRODUCT DOSE OMISSION 94
773 BONE MARROW FAILURE 93
774 FIBROMYALGIA 93
775 GASTRIC DISORDER 93
776 HEPATITIS VIRAL 93
777 LONG QT SYNDROME 93
778 PRESCRIBED UNDERDOSE 93
779 RASH GENERALISED 93
780 TACHYPHRENIA 93
781 TUBULOINTERSTITIAL NEPHRITIS 93
782 BLOOD CALCIUM DECREASED 92
783 EAR PAIN 92
784 RED CELL DISTRIBUTION WIDTH INCREASED 92
785 ARTHROPATHY 91
786 CHOLECYSTITIS 91
787 JOINT INJURY 91
788 MONOCYTE COUNT INCREASED 91
789 MULTIPLE SCLEROSIS 91
790 NERVE INJURY 91
791 SNORING 91
792 BACTERAEMIA 90
793 CONGESTIVE CARDIOMYOPATHY 90
794 DEPENDENCE 90
795 EXTRASYSTOLES 90
796 KETONURIA 90
797 PAIN IN JAW 90
798 HYPOMAGNESAEMIA 89
799 INTERVERTEBRAL DISC PROTRUSION 89
800 MENORRHAGIA 89
801 BLOOD SODIUM INCREASED 88
802 EMBOLISM VENOUS 88
803 FACIAL PAIN 88
804 FACIAL PARALYSIS 88
805 HIATUS HERNIA 88
806 MYELOSUPPRESSION 88
807 NEOPLASM PROGRESSION 88
808 OESOPHAGITIS 88
809 RHEUMATOID ARTHRITIS 88
810 BLOOD PRESSURE ABNORMAL 87
811 CLONUS 87
812 GALLBLADDER DISORDER 87
813 LIMB INJURY 87
814 NEUTROPHILIA 87
815 POST PROCEDURAL COMPLICATION 87
816 POTENTIATING DRUG INTERACTION 87
817 THROAT TIGHTNESS 87
818 BEDRIDDEN 85
819 BODY TEMPERATURE DECREASED 85
820 BREAST PAIN 85
821 DISSEMINATED INTRAVASCULAR COAGULATION 85
822 FAECAL INCONTINENCE 85
823 GENERAL PHYSICAL CONDITION ABNORMAL 85
824 INITIAL INSOMNIA 85
825 LACERATION 85
826 SARS-COV-2 TEST POSITIVE 85
827 SPLENOMEGALY 85
828 TOOTH DISORDER 85
829 BLOOD LACTIC ACID INCREASED 84
830 BRADYPNOEA 84
831 EYE PRURITUS 84
832 FULL BLOOD COUNT DECREASED 84
833 HEMIPARESIS 84
834 LOCALISED INFECTION 84
835 MIDDLE INSOMNIA 84
836 PHARYNGITIS 84
837 SMALL FOR DATES BABY 84
838 TOXIC SKIN ERUPTION 84
839 VITAMIN D DEFICIENCY 84
840 DENTAL CARIES 83
841 EYE IRRITATION 83
842 HYPERSEXUALITY 83
843 WEIGHT FLUCTUATION 83
844 LYMPHOCYTE COUNT INCREASED 82
845 PREGNANCY 82
846 REDUCED FACIAL EXPRESSION 82
847 SENSORY DISTURBANCE 82
848 TOOTHACHE 82
849 AKINESIA 81
850 APRAXIA 81
851 HEPATIC ENCEPHALOPATHY 81
852 HYPOVENTILATION 81
853 NO THERAPEUTIC RESPONSE 81
854 PRE-ECLAMPSIA 81
855 RESPIRATORY ACIDOSIS 81
856 SPINAL OSTEOARTHRITIS 81
857 ARTERIOSCLEROSIS 80
858 COLITIS ULCERATIVE 80
859 DIALYSIS 80
860 DRUG ABUSER 80
861 DRUG ADMINISTRATION ERROR 80
862 SKIN ULCER 80
863 MULTIPLE SCLEROSIS RELAPSE 79
864 OBSTRUCTIVE AIRWAYS DISORDER 79
865 RENAL FAILURE CHRONIC 79
866 TOOTH LOSS 79
867 UPPER GASTROINTESTINAL HAEMORRHAGE 79
868 BLOOD CHLORIDE DECREASED 78
869 CARDIOTOXICITY 78
870 COMPARTMENT SYNDROME 78
871 PAIN OF SKIN 78
872 PULSE ABSENT 78
873 ATRIAL FLUTTER 77
874 BACTERIAL INFECTION 77
875 CAMPTOCORMIA 77
876 DIABETIC NEPHROPATHY 77
877 DYSPHEMIA 77
878 ELECTROCARDIOGRAM T WAVE INVERSION 77
879 FRACTURE 77
880 LYMPHOMA 77
881 NYSTAGMUS 77
882 PROTEINURIA 77
883 SLOW SPEECH 77
884 ALCOHOL USE 76
885 BODY MASS INDEX INCREASED 76
886 GAMBLING DISORDER 76
887 INTESTINAL PERFORATION 76
888 MELAENA 76
889 OSTEOPENIA 76
890 ANAL INCONTINENCE 75
891 BLOOD DISORDER 75
892 BUTTERFLY RASH 75
893 IMPAIRED SELF-CARE 75
894 AGEUSIA 74
895 AMMONIA INCREASED 74
896 MATERNAL DRUGS AFFECTING FOETUS 74
897 RESPIRATION ABNORMAL 74
898 SKIN LACERATION 74
899 ACCIDENTAL EXPOSURE TO PRODUCT 73
900 ANOSMIA 73
901 FEMUR FRACTURE 73
902 INCORRECT ROUTE OF DRUG ADMINISTRATION 73
903 INTESTINAL PSEUDO-OBSTRUCTION 73
904 PRESSURE OF SPEECH 73
905 INTENTIONAL DOSE OMISSION 72
906 MUSCLE CONTRACTIONS INVOLUNTARY 72
907 PANIC DISORDER 72
908 SINUS DISORDER 72
909 TRANSFUSION 72
910 UROSEPSIS 72
911 GASTROINTESTINAL NECROSIS 71
912 GAZE PALSY 71
913 HAEMORRHAGE INTRACRANIAL 71
914 LEFT VENTRICULAR HYPERTROPHY 71
915 SMALL INTESTINAL OBSTRUCTION 71
916 SPINAL FRACTURE 71
917 THYROID DISORDER 71
918 ABSCESS 70
919 HYPERCAPNIA 70
920 ANURIA 69
921 BLOOD MAGNESIUM DECREASED 69
922 BLUNTED AFFECT 69
923 BUNDLE BRANCH BLOCK LEFT 69
924 CROHN^S DISEASE 69
925 DECREASED INTEREST 69
926 DIVERTICULITIS 69
927 FEELING GUILTY 69
928 NEGATIVE THOUGHTS 69
929 RENAL TUBULAR NECROSIS 69
930 RESPIRATORY ALKALOSIS 69
931 TROPONIN T INCREASED 69
932 CARDIAC FAILURE ACUTE 68
933 CEREBRAL DISORDER 68
934 CLOSTRIDIUM DIFFICILE COLITIS 68
935 ENCEPHALITIS AUTOIMMUNE 68
936 FAILURE TO THRIVE 68
937 FOOT FRACTURE 68
938 INAPPROPRIATE AFFECT 68
939 MEAN CELL HAEMOGLOBIN DECREASED 68
940 OROMANDIBULAR DYSTONIA 68
941 PHYSICAL ASSAULT 68
942 POLYNEUROPATHY 68
943 RESTING TREMOR 68
944 SINUS RHYTHM 68
945 ALCOHOLISM 67
946 DEAFNESS 67
947 DERMATITIS ALLERGIC 67
948 DIABETES INSIPIDUS 67
949 DRUG DISPENSING ERROR 67
950 END STAGE RENAL DISEASE 67
951 GLOMERULAR FILTRATION RATE DECREASED 67
952 HYPERTHYROIDISM 67
953 HYPOPHOSPHATAEMIA 67
954 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 67
955 INTRACRANIAL PRESSURE INCREASED 67
956 LUPUS NEPHRITIS 67
957 NEONATAL RESPIRATORY DISTRESS SYNDROME 67
958 ORAL PAIN 67
959 PNEUMOTHORAX 67
960 SUSPICIOUSNESS 67
961 TONGUE DISORDER 67
962 VENTRICULAR HYPOKINESIA 67
963 ADRENAL INSUFFICIENCY 66
964 ANKLE FRACTURE 66
965 BLOOD TEST ABNORMAL 66
966 DELUSIONAL DISORDER, UNSPECIFIED TYPE 66
967 EAR INFECTION 66
968 HAEMOLYTIC ANAEMIA 66
969 HEPATITIS ACUTE 66
970 MENSTRUAL DISORDER 66
971 OSTEOMYELITIS 66
972 SCRATCH 66
973 SUBDURAL HAEMATOMA 66
974 BEZOAR 65
975 CENTRAL NERVOUS SYSTEM LUPUS 65
976 DIZZINESS POSTURAL 65
977 EMPHYSEMA 65
978 FUNGAL INFECTION 65
979 INTESTINAL ISCHAEMIA 65
980 SCHIZOPHRENIA, PARANOID TYPE 65
981 SELF-MEDICATION 65
982 ULCER 65
983 UPPER LIMB FRACTURE 65
984 URINARY HESITATION 65
985 ABDOMINAL PAIN LOWER 64
986 DISORGANISED SPEECH 64
987 FRUSTRATION TOLERANCE DECREASED 64
988 INTENTIONAL MISUSE 64
989 NEUROLOGICAL SYMPTOM 64
990 OBSESSIVE-COMPULSIVE SYMPTOM 64
991 SUPRAVENTRICULAR EXTRASYSTOLES 64
992 ACUTE CORONARY SYNDROME 63
993 BACK DISORDER 63
994 BREAST CANCER METASTATIC 63
995 CHROMATURIA 63
996 FEEDING DISORDER NEONATAL 63
997 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 63
998 MASS 63
999 MYOPATHY 63